Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2004, Vol. 104, No. 1, pp. 128-134.
Prepublished online as a Blood First Edition Paper on March 16, 2004; DOI 10.1182/blood-2003-10-3530.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-10-3530v1
104/1/128    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kravtsov, D. V
Right arrow Articles by Gailani, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kravtsov, D. V
Right arrow Articles by Gailani, D.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted October 15, 2003
Accepted February 26, 2004

Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain

Dmitri V Kravtsov, Wenman Wu, Joost C Meijers, Mao-Fu Sun, Morey A Blinder, Thao P Dang, Hongli Wang, and David Gailani*

Pathology, Vanderbilt University, Nashville, TN, USA
Shanghai Institute of Hematology, Ruijin Hospital affiliated to Shanghai Second Medical University, Shanghai, China
Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Medicine, Washington University School of Medicine, St. Louis, MO, USA
Medicine, Vanderbilt University, Nashville, TN, USA
Pathology, Vanderbilt University, Nashville, TN, USA; Medicine, Vanderbilt University, Nashville, TN, USA

* Corresponding author; email: dave.gailani{at}vanderbilt.edu.

The bleeding diathesis associated with hereditary factor XI (fXI) deficiency is prevalent in Ashkenazi Jews, in whom the disorder appears to be an autosomal recessive condition. The homodimeric structure of fXI implies that the product of a single mutant allele could confer disease in a dominant manner through formation of heterodimers with wild type polypeptide. We studied two unrelated patients with fXI levels <20% of normal, and family histories indicating dominant disease transmission. Both are heterozygous for single amino acid substitutions in the fXI catalytic domain (Gly400Val and Trp569Ser). Neither mutant is secreted by transfected fibroblasts. In co-transfection experiments with a wild type fXI construct, constructs with mutations common in Ashkenazi Jews (Glu117Stop and Phe283Leu), and a variant with a severe defect in dimer formation (fXI-Gly350Glu) have little effect on wild type fXI secretion. In contrast, co-transfection with fXI-Gly400Val or fXI-Trp569Ser reduces wild type secretion ~50%, consistent with a dominant negative effect. Immunoprecipitation of cell lysates confirmed that fXI-Gly400Val forms intracellular dimers. The data support a model in which non-secretable mutant fXI polypeptides trap wild type polypeptides within cells through heterodimer formation, resulting in lower plasma fXI levels than in heterozygotes for mutations that cause autosomal recessive fXI deficiency.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

A new mechanism for inherited factor XI deficiency
Uri Seligsohn
Blood 2004 104: 7-8. [Full Text] [PDF]



This article has been cited by other articles:


Home page
haematolHome page
G. Zadra, R. Asselta, M. L. Tenchini, G. Castaman, U. Seligsohn, P. M. Mannucci, and S. Duga
Simultaneous genotyping of coagulation factor XI type II and type III mutations by multiplex real-time polymerase chain reaction to determine their prevalence in healthy and factor XI-deficient Italians
Haematologica, May 1, 2008; 93(5): 715 - 721.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. V. Kravtsov, P. E. Monahan, and D. Gailani
A classification system for cross-reactive material-negative factor XI deficiency
Blood, June 15, 2005; 105(12): 4671 - 4673.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Mitchell, L. Dai, G. Savidge, and A. Alhaq
An Alu-mediated 31.5-kb deletion as the cause of factor XI deficiency in 2 unrelated patients
Blood, October 15, 2004; 104(8): 2394 - 2396.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. M. Mannucci, S. Duga, and F. Peyvandi
Recessively inherited coagulation disorders
Blood, September 1, 2004; 104(5): 1243 - 1252.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020